NLRP3 and Alzheimer disease: Experiments by Michael T. Heneka et al. demonstrated that NLRP3 or caspase-1 deficiency enhanced microglial Aβ phagocytosis, while activation of NLRP3 inhibited microglial Aβ clearance in Alzheimer's disease [97].